title: Concise review of the management of hepatitis C.
abstract: Hepatitis C is the most common blood-borne infection in the US affecting at least 2.7 million Americans today. The majority of infected patients remain asymptomatic until the end-stages of the disease, making the infection difficult to identify, study, and treat.
authors.affiliation: Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208019, New Haven, CT 06520-8019, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Addesa
authors.forename: V J
authors.initials: VJ
authors.lastname: Navarro
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D006526:Hepatitis C / Q000175:diagnosis / Q000628:therapy* / Q000635:transmission; D019698:Hepatitis C, Chronic / Q000175:diagnosis; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons